BWS
ROIV icon

Buck Wealth Strategies’s Roivant Sciences ROIV Stock Holding History

Buck Wealth Strategies’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$389 Buy
+11
New +$325 ﹤0.01% 1032

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PDM
Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Buck Wealth Strategies's ROIV Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Roivant Sciences (ROIV) in Q2 2026: 11 shares worth $389. The stake represents ﹤0.01% of the portfolio and ranks #1032 among its holdings.

235 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Buck Wealth Strategies held 11 shares of Roivant Sciences worth $389 as of Q2 2026.
  • Roivant Sciences was a new Buck Wealth Strategies position in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #1032 holding.
  • 235 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.